Panitumumab: in the treatment of metastatic colorectal cancer (Q36651665)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2006

Language	Label	Description	Also known as
English	Panitumumab: in the treatment of metastatic colorectal cancer	scientific article published on January 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

Panitumumab: in the treatment of metastatic colorectal cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

Antona J Wagstaff

2

object named as

Antona J Wagstaff

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

author name string

Sheridan M Hoy

1

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

66

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

2005-14; discussion 2015-6

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17100412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted therapies in the treatment of colorectal cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17100412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17100412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel therapeutics in colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17100412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17100412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17100412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/17100412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies in the treatment of colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17100412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor inhibition strategies in oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/17100412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease management considerations: disease management considerations

1 reference

https://pubmed.ncbi.nlm.nih.gov/17100412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fully human therapeutic monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17100412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic monoclonal antibodies in oncology.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17100412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/17100412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Technology evaluation: ABX-EGF, Abgenix/Amgen

1 reference

https://pubmed.ncbi.nlm.nih.gov/17100412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic colorectal cancer: systemic treatment in the new millennium

1 reference

https://pubmed.ncbi.nlm.nih.gov/17100412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trial design and end points for epidermal growth factor receptor-targeted therapies: implications for drug development and practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/17100412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-200666150-00011

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Dimensions Publication ID

0 references

release_oipk5tkv6zakxpv6oicburplay

1 reference

https://api.fatcat.wiki/v0/release/oipk5tkv6zakxpv6oicburplay

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36651665&oldid=2199142862"